Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Stem Cell Transplant in HL and NHL
NCT03125642Phase 2Recruiting
- Sponsor
- Masonic Cancer Center
- Start
- Apr 2017
- Primary completion
- Sep 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous peripheral blood stem cell transplantation in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Masonic Cancer Center. Started Apr 2017; status: recruiting.
02
Drugs
autologous peripheral blood stem cell transplantation
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT03125642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03125642.